Blueprint Medicines
BPMC
$105.56
Share price
-0.75%
Change (1 day)
85.88%
Change (1 year)
Categories
Blueprint Medicines (BPMC) - Total assets
Total assets on the balance sheet as of March 2024 : $1.03 B
According to Blueprint Medicines 's latest financial reports the company's total assets are $1.03 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Blueprint Medicines - Total assets on balance sheet (from 2014 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $1.04 B | -22.27% |
| 2022-12-31 | $1.34 B | 7.8% |
| 2021-12-31 | $1.25 B | -27.13% |
| 2020-12-31 | $1.71 B | 142.82% |
| 2019-12-31 | $0.70 B | 31.02% |
| 2018-12-31 | $0.54 B | -24.54% |
| 2017-12-31 | $0.71 B | 153.09% |
| 2016-12-31 | $0.28 B | 58.08% |
| 2015-12-31 | $0.17 B | 258.33% |
| 2014-12-31 | $49.92 M | 1107.38% |
| 2013-12-31 | $4.13 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pacific Biosciences
PACB | $1.66 B | 60.80% | 🇺🇸 USA |
 OPKO Health
OPK | $1.97 B | 90.09% | 🇺🇸 USA |
 Acceleron Pharma XLRN | N/A | N/A | 🇺🇸 USA |
 Isoray
ISR | $58.27 M | -94.39% | 🇺🇸 USA |